Editas Medicine Stock Options Expiring on 17th of January 2025
| EDIT Stock | USD 1.99 0.11 5.24% |
Editas Medicine's latest option contracts expiring on 2025-01-17 are carrying combined implied volatility of 1.13 with a put-to-call open interest ratio of 0.11 over 21 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2025-01-17. The total put volume is at 54.0, with calls trading at the volume of 54.0. This yields a 0.29 put-to-call volume ratio.
Open Interest Against 2025-01-17 Option Contracts
Editas Medicine option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Editas Medicine's lending market. For example, when Editas Medicine's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Editas Medicine, he or she must hedge the risk by shorting Editas Medicine stock over its option's life.
2025-01-17
The chart above shows Editas Medicine's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Editas Medicine's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Editas Medicine's option, there is no secondary market available for investors to trade.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Editas Medicine. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. Editas Current Options Market Mood
Editas Medicine's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Editas Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Editas Medicine's options investors are not very successful. Editas Medicine's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Editas contract
Base on the Rule 16, the options market is currently suggesting that Editas Medicine will have an average daily up or down price movement of about 0.0706% per day over the life of the 2025-01-17 option contract. With Editas Medicine trading at USD 1.99, that is roughly USD 0.001405. If you think that the market is fully incorporating Editas Medicine's daily price movement you should consider buying Editas Medicine options at the current volatility level of 1.13%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Editas |
Editas Medicine Option Chain
When Editas Medicine's strike price is surpassing the current stock price, the option contract against Editas Medicine stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Editas Medicine's option chain is a display of a range of information that helps investors for ways to trade options on Editas. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Editas. It also shows strike prices and maturity days for a Editas Medicine against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | EDIT Option Call 17-01-2025 2 | 1804 | 2025-01-17 | 0.0 - 0.0 | 0.2 | Out |
Call | EDIT Option Call 17-01-2025 5 | 3099 | 2025-01-17 | 0.0 - 0.0 | 0.01 | Out |
Call | EDIT Option Call 17-01-2025 7 | 3213 | 2025-01-17 | 0.0 - 0.0 | 0.05 | Out |
Call | EDIT Option Call 17-01-2025 10 | 2682 | 2025-01-17 | 0.0 - 0.0 | 0.03 | Out |
Call | EDIT Option Call 17-01-2025 12 | 760 | 2025-01-17 | 0.0 - 0.0 | 0.05 | Out |
Call | EDIT Option Call 17-01-2025 15 | 0 | 2025-01-17 | 0.0 - 0.45 | 0.1 | |
Call | EDIT Option Call 17-01-2025 17 | 119 | 2025-01-17 | 0.0 - 0.15 | 0.02 | Out |
Call | EDIT Option Call 17-01-2025 20 | 825 | 2025-01-17 | 0.0 - 0.0 | 0.06 | Out |
Call | EDIT Option Call 17-01-2025 22 | 342 | 2025-01-17 | 0.0 - 0.0 | 0.1 | Out |
Call | EDIT Option Call 17-01-2025 25 | 1336 | 2025-01-17 | 0.0 - 0.2 | 0.05 | Out |
Call | EDIT Option Call 17-01-2025 30 | 2055 | 2025-01-17 | 0.0 - 0.0 | 0.03 | Out |
Put | EDIT Option Put 17-01-2025 2 | 659 | 2025-01-17 | 0.0 - 0.0 | 0.45 | In |
Put | EDIT Option Put 17-01-2025 5 | 733 | 2025-01-17 | 0.0 - 0.0 | 3.0 | In |
Put | EDIT Option Put 17-01-2025 7 | 381 | 2025-01-17 | 0.0 - 0.0 | 5.5 | In |
Put | EDIT Option Put 17-01-2025 10 | 10 | 2025-01-17 | 0.0 - 0.0 | 7.4 | In |
Put | EDIT Option Put 17-01-2025 12 | 0 | 2025-01-17 | 8.7 - 9.2 | 8.3 | In |
Put | EDIT Option Put 17-01-2025 15 | 20 | 2025-01-17 | 9.6 - 12.0 | 9.36 | In |
Put | EDIT Option Put 17-01-2025 17 | 2 | 2025-01-17 | 10.3 - 10.8 | 8.96 | In |
Put | EDIT Option Put 17-01-2025 22 | 5 | 2025-01-17 | 12.7 - 13.7 | 12.2 | In |
Put | EDIT Option Put 17-01-2025 25 | 3 | 2025-01-17 | 15.8 - 17.3 | 17.85 | In |
Put | EDIT Option Put 17-01-2025 30 | 0 | 2025-01-17 | 26.3 - 28.9 | 26.4 | In |
Editas Medicine Market Cap Over Time
Market Cap |
| Timeline |
Editas Total Stockholder Equity
Total Stockholder Equity |
|
Editas Medicine Corporate Management
| Bruce Eaton | Exec Officer | Profile | |
| Cristi Barnett | Corporate Relations | Profile | |
| Charlene JD | Executive Counsel | Profile | |
| Michelle Robertson | Principal CFO | Profile |
Additional Tools for Editas Stock Analysis
When running Editas Medicine's price analysis, check to measure Editas Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Editas Medicine is operating at the current time. Most of Editas Medicine's value examination focuses on studying past and present price action to predict the probability of Editas Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Editas Medicine's price. Additionally, you may evaluate how the addition of Editas Medicine to your portfolios can decrease your overall portfolio volatility.